Results about: Kennedy’s disease

Researchers at IRB Barcelona identify a possible therapeutic target for Kennedy´s disease and prostate cancer

Activation of the chaperone protein Hsp70 leads to a decrease in the formation of androgen receptor aggregates, which give rise to muscular atrophy in patients with Kennedy´s disease, a rare condition for which no treatment is available.

The results may also be useful in the search for a treatment for castration-resistant prostate cancer, a disease that causes 30,000 death a year in Europe and for which there is no treatment.

The study, which has been published in Nature Communications, is a collaboration with the University of California San Francisco and the University of Michigan. 

Researchers at IRB Barcelona discover the structural consequences of the mutation that causes Kennedy disease

Kennedy’s disease is an untreatable neuromuscular disorder considered a rare disease

A study led by Xavier Salvatella may pave the way for new lines of treatment for Kennedy’s disease